Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Automated Insulin Delivery (AID) Systems
Treatment for Diabetes mellitus type 1
Typical Dosage: Automated algorithm-driven insulin delivery
Effectiveness
90%
Safety Score
55%
Clinical Trials
45
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
Automated algorithm-driven insulin delivery
Time to Effect
Days-weeks for optimized control
Treatment Duration
Lifetime
Evidence Quality
HIGHConfidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$5,000
Monitoring:$9,000
Side Effect Mgmt:$500
Total Annual:$14,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$80,000/QALY
QALYs Gained
2
Outcome-Based Costs
Cost per Responder
$16,111
Comparison vs Multiple Daily Injections (MDI) + SMBG
Cost Difference
+$7,500/year
More expensive
QALY Difference
+0.20 QALYs
Better outcomes
Dominance
No dominance
Automated Insulin Delivery (AID) Systems Outcomes
for Diabetes mellitus type 1
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+90%
Common Side Effects
Hypoglycemia
+40%
Infusion site irritation/occlusion
+15%
Diabetic Ketoacidosis (DKA)
+1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
10 active trials recruiting for Automated Insulin Delivery (AID) Systems in Diabetes mellitus type 1
Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D
NCT07501338NOT YET RECRUITINGNA
16 participants
INTERVENTIONAL
Palo Alto, United States
Started: Mar 1, 2026
Commercial or Open Source Closed Loop Impact on Pregnancy Study
NCT06654713RECRUITING
1K participants
OBSERVATIONAL
San Francisco, United States
Started: Mar 13, 2025
Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes
NCT06158503RECRUITING
25 participants
OBSERVATIONAL
Montreal, Canada +1 more
Started: Feb 1, 2025
The Steno Free Trial: AID to Adults with New-onset of Type 1 Diabetes
NCT06586632NOT YET RECRUITINGNA
60 participants
INTERVENTIONAL
Started: Oct 1, 2024
Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes
NCT07401901NOT YET RECRUITINGNA
230 participants
INTERVENTIONAL
Caen, France +20 more
Started: Oct 15, 2026
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
NCT07287943RECRUITINGNA
34 participants
INTERVENTIONAL
Indianapolis, United States
Started: Feb 9, 2026
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
NCT07348432RECRUITING
106 participants
OBSERVATIONAL
Montreal, Canada
Started: Jul 29, 2024
Automated Insulin for Management of Intrapartum Glycemia
NCT06883344RECRUITINGNA
150 participants
INTERVENTIONAL
San Diego, United States +1 more
Started: Dec 5, 2025
Automated Insulin Delivery for Type 1 Diabetes - Beyond Glucose Metrics
NCT06469593RECRUITINGNA
200 participants
INTERVENTIONAL
Herlev, Denmark +2 more
Started: Jun 15, 2024
Closed Loop Context Aware AID
NCT06676657RECRUITINGNA
10 participants
INTERVENTIONAL
Portland, United States
Started: Nov 22, 2024
Completed Clinical Trials
10 completed trials for Automated Insulin Delivery (AID) Systems in Diabetes mellitus type 1
Safety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 Diabetes
NCT05626725COMPLETED
76 participants
OBSERVATIONAL
Montreal, Canada
Started: Dec 1, 2022
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes
NCT03890003COMPLETEDNA
10 participants
INTERVENTIONAL
Santa Barbara, United States
Started: Mar 28, 2019
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
NCT03849612COMPLETEDNA
10 participants
INTERVENTIONAL
Walnut Creek, United States
Started: Feb 21, 2019
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)
NCT03743285COMPLETEDNA
10 participants
INTERVENTIONAL
Renton, United States
Started: Nov 14, 2018
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
NCT07212179COMPLETEDNA
2 participants
INTERVENTIONAL
Charlottesville, United States
Started: Mar 3, 2026
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges
NCT03848767COMPLETEDNA
10 participants
INTERVENTIONAL
Renton, United States
Started: Feb 20, 2019
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
NCT03367390COMPLETEDPHASE1
30 participants
INTERVENTIONAL
Renton, United States
Started: Nov 8, 2017
Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes
NCT05243628COMPLETEDPHASE4
33 participants
INTERVENTIONAL
Loma Linda, United States +1 more
Started: Mar 31, 2022
Automated Insulin Delivery in Pregnant Patients With Type 1 Diabetes With Extension Into Outpatient at Home
NCT04492566COMPLETEDNA
10 participants
INTERVENTIONAL
Santa Barbara, United States +2 more
Started: Jul 27, 2020
Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery
NCT04784637COMPLETEDNA
31 participants
INTERVENTIONAL
Charlottesville, United States
Started: Jul 23, 2021
Showing 20 of 56 total trials